N-Boc-N-Fmoc-L-Lysine for PDC Linker Attachment: Isomeric Purity & HPLC Tailing
Isomeric Purity Thresholds for N-Boc-N-Fmoc-L-Lysine in PDC Linker Attachment: COA vs. Functional Requirements
When sourcing N-alpha-Boc-N-epsilon-Fmoc-L-lysine for peptide-drug conjugate (PDC) linker attachment, the isomeric purity is not merely a certificate of analysis (COA) checkbox—it is a functional necessity. The molecule’s orthogonal protecting groups (Boc on the α-amine, Fmoc on the ε-amine) are designed for sequential deprotection, but the presence of regioisomers (e.g., N-α-Fmoc-N-ε-Boc-L-lysine) can derail conjugation efficiency. In our experience, even a 0.5% isomeric impurity can lead to off-target linker attachment, compromising the homogeneity of the final PDC. For process chemists, the acceptable diastereomer ratio often hinges on the specific conjugation chemistry. While a COA might report 99.0% purity by HPLC, the functional requirement for clinical-grade PDC manufacturing may demand <0.3% of the undesired isomer. This is where a protected lysine supplier’s process control becomes critical. We have observed that batches produced via selective acylation routes, rather than mixed anhydride methods, consistently yield lower isomeric impurities. However, please refer to the batch-specific COA for exact specifications. For orthogonal cyclic peptide workflows, the isomeric purity directly impacts cyclization yields, as discussed in our article on N-Boc-N-Fmoc-L-Lysine in orthogonal cyclic peptide conjugation workflows.
Chromatographic Resolution of Mono-Protected Lysine Isomers: Critical Pair Separation and Retention Time Windows
Separating N-Boc-N-Fmoc-L-Lysine from its regioisomer is a chromatographic challenge that demands meticulous method development. The critical pair—N-α-Boc-N-ε-Fmoc-L-lysine and N-α-Fmoc-N-ε-Boc-L-lysine—often co-elute on standard C18 columns under generic gradients. From field troubleshooting, we have found that a phenyl-hexyl stationary phase with a shallow acetonitrile gradient (0.1% TFA) can achieve baseline resolution, with retention time windows of 12.5 ± 0.3 min for the desired isomer and 13.1 ± 0.3 min for the impurity. However, column temperature is a non-standard parameter that can make or break the separation: at sub-ambient temperatures (10–15°C), we have observed improved selectivity due to reduced conformational flexibility of the lysine side chain, but this can also increase backpressure and cause peak broadening if the system is not properly equilibrated. For routine quality control, a resolution factor (Rs) > 2.0 is recommended, but for PDC linker applications, we advise validating the method with spiked samples to confirm that trace isomer detection (LOQ ≤ 0.05%) is achievable. This is particularly important when scaling up, as bulk handling can introduce thermal history that affects chromatographic behavior, a topic we explore in bulk N-Boc-N-Fmoc-L-Lysine handling: resin swelling and cold-chain clumping in automated SPPS.
HPLC Peak Tailing Prevention: Impact of Trace Impurities on Conjugation Purification and Batch Rejection Criteria
Peak tailing in HPLC analysis of N-Boc-N-Fmoc-L-Lysine is more than an aesthetic nuisance—it can mask low-level impurities that later interfere with PDC conjugation purification. In our experience, tailing is often caused by trace amounts of des-Boc or des-Fmoc byproducts, which act as silanol-interacting species on the column. A non-standard field observation: the presence of residual DMF from the manufacturing process can exacerbate tailing by altering the mobile phase’s solvation strength, leading to inconsistent retention times. To mitigate this, we recommend a column wash with 100% acetonitrile after every 20 injections and using a guard column with identical stationary phase. For process-scale PDC manufacturing, batch rejection criteria should include not only isomeric purity but also a tailing factor (Tf) ≤ 1.5 at 10% peak height. If tailing exceeds this, it may indicate the presence of amino acid derivative impurities that could co-elute with the product during preparative HPLC of the conjugated PDC, leading to costly repurification. Below is a comparison of typical purity grades and their impact on HPLC performance:
| Grade | Purity (HPLC, %) | Isomeric Impurity (%) | Tailing Factor (Tf) | Recommended Use |
|---|---|---|---|---|
| Research | ≥ 98.0 | ≤ 1.0 | ≤ 2.0 | Early-stage peptide synthesis |
| GMP Intermediate | ≥ 99.0 | ≤ 0.5 | ≤ 1.5 | Pre-clinical PDC development |
| High Purity | ≥ 99.5 | ≤ 0.2 | ≤ 1.2 | Clinical-grade PDC manufacturing |
These values are typical; please refer to the batch-specific COA for exact data. As a global manufacturer, we ensure that every lot is tested under validated conditions to meet these stringent criteria.
Bulk Packaging and Stability Considerations for N-Boc-N-Fmoc-L-Lysine in Process-Scale PDC Manufacturing
When ordering N-Boc-N-Fmoc-L-Lysine in bulk for process-scale PDC manufacturing, packaging and stability are as critical as chemical purity. The compound is hygroscopic and prone to hydrolysis of the Fmoc group under humid conditions, which can generate des-Fmoc impurity that causes HPLC tailing. We supply the product in 210L drums or IBCs under nitrogen blanket, with desiccant packs to maintain dryness. A non-standard stability concern: during cold-chain shipping, the powder can undergo static clumping due to triboelectric charging, which may affect flowability in automated solid-phase peptide synthesis (SPPS) resin loaders. To mitigate this, we recommend equilibrating the drums to room temperature under nitrogen before opening and using anti-static funnels during transfer. For long-term storage, -20°C is ideal, but repeated freeze-thaw cycles should be avoided as they can induce amorphous-to-crystalline phase transitions that alter dissolution kinetics. Our synthesis route is optimized to minimize residual solvents, ensuring that the product meets ICH Q3C guidelines for Class 2 solvents. As a peptide building block supplier, we understand that supply chain reliability is paramount; our manufacturing process is scaled to deliver tonnage quantities with consistent quality.
Frequently Asked Questions
What are acceptable diastereomer ratios for N-Boc-N-Fmoc-L-Lysine in PDC conjugation workflows?
For most PDC linker attachments, a diastereomer ratio of ≥ 99:1 (desired isomer to undesired) is acceptable for early-stage development. However, for clinical-grade manufacturing, we recommend ≥ 99.5:0.5 to minimize off-target conjugation. The exact ratio should be validated against your specific conjugation efficiency and purification yield.
How do you validate an HPLC method for trace isomer detection in N-Boc-N-Fmoc-L-Lysine?
Method validation should include specificity (resolution > 2.0 between isomers), linearity (R² > 0.999 over 50–150% of specification limit), accuracy (spike recovery 95–105%), and LOQ (≤ 0.05% for the undesired isomer). We also recommend forced degradation studies to ensure that the method can detect des-Boc and des-Fmoc impurities that may co-elute.
What are the batch acceptance criteria for clinical-grade PDC manufacturing using N-Boc-N-Fmoc-L-Lysine?
Typical acceptance criteria include: purity ≥ 99.5% by HPLC, isomeric impurity ≤ 0.2%, tailing factor ≤ 1.2, residual solvents within ICH limits, and heavy metals ≤ 10 ppm. Additionally, the product should pass identity testing by IR and specific rotation. Custom specifications can be agreed upon based on your process requirements.
What is the sidechain of L-lysine?
The sidechain of L-lysine is a 4-aminobutyl group (-CH2-CH2-CH2-CH2-NH2). In N-Boc-N-Fmoc-L-Lysine, the ε-amine of this sidechain is protected by the Fmoc group, while the α-amine is protected by Boc.
Can you dissolve L-lysine in water?
L-lysine itself is freely soluble in water. However, N-Boc-N-Fmoc-L-Lysine is a protected derivative with limited water solubility; it is typically dissolved in organic solvents like DMF or DMSO for peptide synthesis.
What is the CAS number of Fmoc lysine?
There are multiple Fmoc-protected lysine derivatives. For Fmoc-Lys(Boc)-OH, the CAS is 71989-26-9. For N-Boc-N-Fmoc-L-Lysine, the CAS is 84624-27-1.
What are the pKa values of ionizable groups in lysine?
In free lysine, the α-COOH has a pKa of ~2.2, the α-NH3+ ~9.0, and the ε-NH3+ ~10.5. In N-Boc-N-Fmoc-L-Lysine, the protecting groups mask these ionizable amines, altering the pKa profile significantly.
Sourcing and Technical Support
As a dedicated global manufacturer of N-Boc-N-Fmoc-L-Lysine, we offer high purity batches with comprehensive COA documentation, including isomeric impurity profiles and HPLC tailing data. Our custom synthesis capabilities allow us to tailor specifications to your PDC linker attachment needs, and our bulk price structure ensures cost-efficiency for process-scale campaigns. For more details, visit our product page: N-Boc-N-Fmoc-L-Lysine for high-purity peptide synthesis. Ready to optimize your supply chain? Reach out to our logistics team today for comprehensive specifications and tonnage availability.